Development of an ELISA for the determination of the major haptoglobin phenotype: An interesting technical development and its potential consequences

Clinical Chemistry

Volumn 50, Issue 11, 2004, Pages 1972-1973

  Delanghe, Joris R ^a   De Buyzere, Marc L ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HAPTOGLOBIN;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; CARDIOVASCULAR DISEASE; CLINICAL LABORATORY; DIABETES MELLITUS; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HEMOLYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALARIA; OUTCOMES RESEARCH; PHENOTYPE; RISK FACTOR; TUBERCULOSIS;

ENZYME-LINKED IMMUNOSORBENT ASSAY; HAPTOGLOBINS; HUMANS; IMMUNOGLOBULIN FRAGMENTS; PEPTIDE LIBRARY; PHENOTYPE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 7044231469     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.040774     Document Type: Editorial

References (18)

1. Levy NS, Levy AP. ELISA for the determination of the haptoglobin phenotype. Clin Chem 2004;50:2148-50.
2. Langlois M, Delanghe J. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996;42:1589-600.
3. Feldhaus M, Siegel R. Yeast display of antibody fragments: a discovery and characterization platform. J Immunol Methods 2004;290:69-80.
4. Lecerf JM, Shirley TL, Zhu Q, Kazantsev A, Amersdorfer P, Housman DE, et al. Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease. Proc Natl Acad Sci U S A 2001;98:4764-9.
5. Smetsers TF, van de Westerlo EM, ten Dam GB, Overes IM, Schalkwijk J, van Muijen GN, et al. Human single-chain antibodies reactive with native chondroitin sulfate detect chondroitin sulfate alterations in melanoma and psoriasis. J Invest Dermatol 2004;122:707-16.
6. Pini A, Bracci L. Phage display of antibody fragments. Curr Protein Pept Sci 2000;1:155-69.
7. Wuyts B, Delanghe JR, Kasvosve I, Langlois MR, De Buyzere ML, Janssens J. A new method for fast haptoglobin phenotyping and hemoglobin binding capacity calculation based on capillary zone electrophoresis. Clin Chem Lab Med 2000;38:715-20.
8. Katnik I, Steuden I, Pupek M, Wiedlocha A, Dobryszycka W. Monoclonal antibodies against human haptoglobin. Hybridoma 1989;8:551-60.
9. Koch W, Latz W, Eichinger M, Roguin A, Levy AP, Schomig A, et al. Genotyping of the common haptoglobin Hp 1/2 polymorphism based on PCR. Clin Chem 2002;48:1377-82.
10. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, et al. Identification of the haemoglobin scavenger receptor. Nature 2001;409:198-201.
11. Delanghe J, Langlois M. Haptoglobin polymorphism and body iron stores. Clin Chem Lab Med 2002;40:212-6.
12. Van Vlierberghe H, Langlois M, Delanghe J. Haptoglobin polymorphisms and iron homeostasis in health and in disease. Clin Chim Acta 2004;345:35-42.
13. Langlois MR, Delanghe JR, De Buyzere ML, Bernard DR, Ouyang J. Effect of haptoglobin on the metabolism of vitamin C. Am J Clin Nutr 1997;66:606-10.
14. Delanghe JR, Langlois MR, Boelaert JR, Van Acker J, Van Wanzeele F, van der Groen G, et al. Haptoglobin polymorphism, iron metabolism and mortality in HIV infection. AIDS 1998;12:1027-32.
15. Kasvosve I, Gomo ZA, Mvundura E, Moyo VM, Saungweme T, Khumalo H, et al. Haptoglobin polymorphism and mortality in patients with tuberculosis. Int J Tuberc Lung Dis 2000;4:771-5.
16. Quaye IK, Ekuban FA, Goka BQ, Adabayeri V, Kurtzhals JA, Gyan B, et al. Haptoglobin 1-1 is associated with susceptibility to severe Plasmodium falciparurn malaria. Trans R Soc Trop Med Hyg 2000;94;216-9.
17. Levy AP, Hochberg I, Jablonski K, Resnick H, Best L, Lee ET, et al. Haptoglobin phenotype and the risk of cardiovascular disease in individuals with diabetes. The Strong Heart Study. J Am Coll Cardiol 2002;40:1984-90.
18. Levy AP, Friedenberg P, Lotan R, Ouyang P, Tripputi M, Higginson L, et al. The effect of vitamin therapy on the progression of coronary artery atherosclerosis varies by haptoglobin type in postmenopausal women. Diabetes Care 2004;27:925-30.